DiNAQOR Acquires EHT Technologies GmbH to Advance Engineered Heart Tissue R&D Capabilities
- Tuesday, January 19, 2021, 6:25
- Environment
- Add a comment
PFÄFFIKON, Switzerland, Jan. 19, 2021 /PRNewswire/ — DiNAQOR, a gene therapy platform company, today announced that it has acquired EHT Technologies GmbH, a Germany-based engineered heart tissue (EHT) technology platform company. Financial terms of the transaction were not disclosed. EHT…
About the Author
adminasapcorp has written 41823 stories on this site.